How ‘Optimal’ are Optimal Sampling Times for Tyrosine Kinase Inhibitors in Cancer? Practical Considerations Michael B. WardStephanie E. ReuterJennifer H. Martin Leading Article 16 April 2016 Pages: 1171 - 1177
A New Level A Type IVIVC for the Rational Design of Clinical Trials Toward Regulatory Approval of Generic Polymeric Long-Acting Injectables Mahadevabharath R. SomayajiDebarun DasAndrzej Przekwas Current Opinion 27 June 2016 Pages: 1179 - 1190
Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib Richat AbbasPoe-Hirr Hsyu Review Article 25 April 2016 Pages: 1191 - 1204
Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma Yuxiang MaYuehao LinHongyun Zhao Original Research Article 30 April 2016 Pages: 1205 - 1216
Pharmacodynamic Analysis of Morphine Time-to-Remedication Events in Infants and Young Children After Congenital Heart Surgery Mohammed H. ElkomyDavid R. DroverKristi L. Glotzbach Original Research Article 20 April 2016 Pages: 1217 - 1226
Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers Esther PetersJules A. A. C. HeubergerPeter Pickkers Original Research Article Open access 04 May 2016 Pages: 1227 - 1237
Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients Natalia SutimanJoanne Siok Liu LimBalram Chowbay Original Research Article 20 April 2016 Pages: 1239 - 1250
Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor Reza KhosravanRobert J. MotzerBrian I. Rini Original Research Article Open access 06 May 2016 Pages: 1251 - 1269
Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications Min ZhuBenjamin WuSameer Doshi Original Research Article 21 May 2016 Pages: 1271 - 1288
Does Weight Impact Anidulafungin Pharmacokinetics? Vincent J. LempersAnne van RongenRoger J. Brüggemann Short Communication Open access 03 May 2016 Pages: 1289 - 1294